首页> 外文期刊>Hybridoma >Generation and identification of monoclonal antibodies against FNIII domain D of human tenascin-C.
【24h】

Generation and identification of monoclonal antibodies against FNIII domain D of human tenascin-C.

机译:抗人腱糖蛋白C FNIII结构域D的单克隆抗体的产生和鉴定。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Tenascin-C (TN-C), a key component of extracellular matrix (ECM), is strongly expressed in fetal and cancer tissues. Large-molecular-weight variants of TN-C, including different combinations of its alternative spliced FNIII repeats, are specifically expressed in tissues under certain pathological conditions. Here we report the production of monoclonal antibodies (MAbs) against FNIII domain D (FNIII D) of human TN-C. Complementary DNA encoding the FNIII D region was generated by RT-PCR from human osteosarcoma (OS) cell line, and the recombinant FNIII D-GST fusion protein was expressed and purified. Two hybridoma cell lines secreting monoclonal antibodies (MAbs) against FNIII D were obtained by routine murine hybridoma technique. The MAbs were identified by indirect enzyme-linked immunosorbent assay (ELISA), Western blot, and immunohistochemistry (IHC). Both of them were applicable in Western blot and IHC. With our MAbs, we found TN-C was positive in OS and most of it was among the tumor stroma. To conclude, these MAbs to human FNIII D domain of TN-C may be useful for exploring OS pathogenesis and potential clinical application.
机译:肌腱蛋白C(TN-C)是细胞外基质(ECM)的关键成分,在胎儿和癌组织中强烈表达。 TN-C的大分子量变体,包括其替代性剪接的FNIII重复序列的不同组合,在某些病理条件下特别表达于组织中。在这里,我们报告针对人类TN-C的FNIII域D(FNIII D)的单克隆抗体(MAb)的生产。通过RT-PCR从人骨肉瘤(OS)细胞系产生编码FNIII D区域的互补DNA,并表达和纯化重组FNIII D-GST融合蛋白。通过常规鼠杂交瘤技术获得了分泌针对FNIII D的单克隆抗体(MAb)的两种杂交瘤细胞系。通过间接酶联免疫吸附测定(ELISA),蛋白质印迹和免疫组化(IHC)鉴定MAb。它们都适用于蛋白质印迹法和免疫组化。使用我们的单克隆抗体,我们发现TN-C在OS中呈阳性,其中大部分位于肿瘤基质中。总之,这些针对TN-C的人FNIII D结构域的单克隆抗体可能对探索OS发病机理和潜在的临床应用有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号